Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients
- PMID: 7690777
- PMCID: PMC288274
- DOI: 10.1172/JCI116706
Activation of the alternative complement pathway by exposure of phosphatidylethanolamine and phosphatidylserine on erythrocytes from sickle cell disease patients
Abstract
Deoxygenation of erythrocytes from sickle cell anemia (SCA) patients alters membrane phospholipid distribution with increased exposure of phosphatidylethanolamine (PE) and phosphatidylserine (PS) on the outer leaflet. This study investigated whether altered membrane phospholipid exposure on sickle erythrocytes results in complement activation. In vitro deoxygenation of sickle but not normal erythrocytes resulted in complement activation measured by C3 binding. Additional evidence indicated that this activation was the result of the alterations in membrane phospholipids. First, complement was activated by normal erythrocytes after incubation with sodium tetrathionate, which produces similar phospholipid changes. Second, antibody was not required for complement activation by sickle or tetrathionate-treated erythrocytes. Third, the membrane regulatory proteins, decay-accelerating factor (CD55) and the C3b/C4b receptor (CD35), were normal on sickle and tetrathionate-treated erythrocytes. Finally, insertion of PE or PS into normal erythrocytes induced alternative pathway activation. SCA patients in crisis exhibited increased plasma factor Bb levels compared with baseline, and erythrocytes isolated from hospitalized SCA patients had increased levels of bound C3, indicating that alternative pathway activation occurs in vivo. Activation of complement may be a contributing factor in sickle crisis episodes, shortening the life span of erythrocytes and decreasing host defense against infections.
Similar articles
-
Activation of the alternative pathway of complement by calcium-loaded erythrocytes resulting from loss of membrane phospholipid asymmetry.J Lab Clin Med. 1997 Aug;130(2):169-82. doi: 10.1016/s0022-2143(97)90093-7. J Lab Clin Med. 1997. PMID: 9280144
-
Increased adherence of sickled and phosphatidylserine-enriched human erythrocytes to cultured human peripheral blood monocytes.J Clin Invest. 1985 Jun;75(6):1965-72. doi: 10.1172/JCI111913. J Clin Invest. 1985. PMID: 4008648 Free PMC article.
-
Membrane phospholipid organization in pathologic human erythrocytes.Prog Clin Biol Res. 1982;97:137-50. Prog Clin Biol Res. 1982. PMID: 7156165 No abstract available.
-
Regulation and function of transbilayer movement of phosphatidylserine in activated blood platelets and sickle cells.Prog Clin Biol Res. 1988;282:181-92. Prog Clin Biol Res. 1988. PMID: 3071796 Review. No abstract available.
-
Membrane phospholipid organization and vesiculation of erythrocytes in sickle cell anaemia.Clin Haematol. 1985 Feb;14(1):183-200. Clin Haematol. 1985. PMID: 3886236 Review.
Cited by
-
New Therapeutic Strategies in Retinal Vascular Diseases: A Lipid Target, Phosphatidylserine, and Annexin A5-A Future Theranostic Pairing in Ophthalmology.Pharmaceuticals (Basel). 2024 Jul 24;17(8):979. doi: 10.3390/ph17080979. Pharmaceuticals (Basel). 2024. PMID: 39204083 Free PMC article. Review.
-
Clinical promise of next-generation complement therapeutics.Nat Rev Drug Discov. 2019 Sep;18(9):707-729. doi: 10.1038/s41573-019-0031-6. Epub 2019 Jul 19. Nat Rev Drug Discov. 2019. PMID: 31324874 Free PMC article. Review.
-
Neutrophil microdomains: linking heterocellular interactions with vascular injury.Curr Opin Hematol. 2010 Jan;17(1):25-30. doi: 10.1097/MOH.0b013e328333d2a3. Curr Opin Hematol. 2010. PMID: 19923987 Free PMC article. Review.
-
Management of hemolytic transfusion reactions.Hematology Am Soc Hematol Educ Program. 2021 Dec 10;2021(1):704-709. doi: 10.1182/hematology.2021000308. Hematology Am Soc Hematol Educ Program. 2021. PMID: 34889404 Free PMC article. Review.
-
Complement in Sickle Cell Disease: Are We Ready for Prime Time?J Blood Med. 2021 Mar 23;12:177-187. doi: 10.2147/JBM.S287301. eCollection 2021. J Blood Med. 2021. PMID: 33790681 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous